Pancreatic Beta-Cell Protection Market 2028 By Product, Applications | The Insight Partners

Pancreatic Beta-Cell Protection Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Stem Cell Based, Gene Therapies, RNA Based Therapies, Monoclonal Antibodies (MAbs), Phytotherapy); Applications (Hospital, Medical Research Laboratory, Others)

Report Code: TIPRE00011636 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming

MARKET INTRODUCTION

Pancreatic ? cells function as glucose sensors and control GSIS. Insulin from pancreatic ? cells inhibits gluconeogenesis and induces glycogen synthesis in the liver, which is the important organ in controlling blood glucose. Beta cells (? cells) are a type of cell found in pancreatic islets that synthesize and secrete insulin and amylin. Beta cells make up 50–70% of the cells in human islets. In patients with type I or type II diabetes, beta-cell mass and function are diminished, leading to insufficient insulin secretion and hyperglycemia.

MARKET DYNAMICS

The pancreatic beta-cell protection market is driving due to the growing prevalence of chronic diseases and rising diabetic patients. Moreover, the rise in government initiatives to enhance health care facilities, focus on research and increase in research boost the market growth in the forecast period.

MARKET SCOPE

The "Pancreatic Beta-Cell Protection Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of pancreatic beta-cell protection market with detailed market segmentation by product and application. The pancreatic beta-cell protection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in pancreatic beta-cell protection market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The pancreatic beta-cell protection market is segmented on the basis of product and application. Based on product, the market is segmented as stem cell based, gene therapies, RNA based therapies, monoclonal antibodies (mabs) and phytotherapy. On the basis of application, the market is categorized as hospital, medical research laboratory and others.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the pancreatic beta-cell protection market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pancreatic beta-cell protection market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting pancreatic beta-cell protection market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pancreatic beta-cell protection market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the pancreatic beta-cell protection market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from pancreatic beta-cell protection market are anticipated to have lucrative growth opportunities in the future with the rising demand for pancreatic beta-cell protection in the global market. Below mentioned is the list of few companies engaged in the pancreatic beta-cell protection market.

The report also includes the profiles of key players in pancreatic beta-cell protection market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   Beta-Cell NV
  •   Beta-O2 Technologies Ltd
  •   BioLineRx
  •   Boehringer Ingelheim
  •   GalaxoSmithKline
  •   Genentech
  •   Janssen Research and Development
  •   Novartis
  •   Novo Nordisk
  •   Pfizer Inc
  •   Sanofi
  •   Transition Therapeutics

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Pancreatic Beta-Cell Protection Market - By Product
1.3.2 Pancreatic Beta-Cell Protection Market - By Applications
1.3.3 Pancreatic Beta-Cell Protection Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. PANCREATIC BETA-CELL PROTECTION MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. PANCREATIC BETA-CELL PROTECTION MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. PANCREATIC BETA-CELL PROTECTION MARKET - GLOBAL MARKET ANALYSIS
6.1. PANCREATIC BETA-CELL PROTECTION - GLOBAL MARKET OVERVIEW
6.2. PANCREATIC BETA-CELL PROTECTION - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. PANCREATIC BETA-CELL PROTECTION MARKET - REVENUE AND FORECASTS TO 2028 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. STEM CELL BASED
7.3.1. Overview
7.3.2. Stem Cell Based Market Forecast and Analysis
7.4. GENE THERAPIES
7.4.1. Overview
7.4.2. Gene Therapies Market Forecast and Analysis
7.5. RNA BASED THERAPIES
7.5.1. Overview
7.5.2. RNA Based Therapies Market Forecast and Analysis
7.6. MONOCLONAL ANTIBODIES (MABS)
7.6.1. Overview
7.6.2. Monoclonal Antibodies (MAbs) Market Forecast and Analysis
7.7. PHYTOTHERAPY
7.7.1. Overview
7.7.2. Phytotherapy Market Forecast and Analysis
8. PANCREATIC BETA-CELL PROTECTION MARKET - REVENUE AND FORECASTS TO 2028 – APPLICATIONS
8.1. OVERVIEW
8.2. APPLICATIONS MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. MEDICAL RESEARCH LABORATORY
8.4.1. Overview
8.4.2. Medical Research Laboratory Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. PANCREATIC BETA-CELL PROTECTION MARKET REVENUE AND FORECASTS TO 2028 – GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Pancreatic Beta-Cell Protection Market Overview
9.1.2 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.1.3 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.1.4 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.1.5 North America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.1.5.1 United States Pancreatic Beta-Cell Protection Market
9.1.5.1.1 United States Pancreatic Beta-Cell Protection Market by Product
9.1.5.1.2 United States Pancreatic Beta-Cell Protection Market by Applications
9.1.5.2 Canada Pancreatic Beta-Cell Protection Market
9.1.5.2.1 Canada Pancreatic Beta-Cell Protection Market by Product
9.1.5.2.2 Canada Pancreatic Beta-Cell Protection Market by Applications
9.1.5.3 Mexico Pancreatic Beta-Cell Protection Market
9.1.5.3.1 Mexico Pancreatic Beta-Cell Protection Market by Product
9.1.5.3.2 Mexico Pancreatic Beta-Cell Protection Market by Applications
9.2. EUROPE
9.2.1 Europe Pancreatic Beta-Cell Protection Market Overview
9.2.2 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.2.3 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.2.4 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.2.5 Europe Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Pancreatic Beta-Cell Protection Market
9.2.5.1.1 Germany Pancreatic Beta-Cell Protection Market by Product
9.2.5.1.2 Germany Pancreatic Beta-Cell Protection Market by Applications
9.2.5.2 France Pancreatic Beta-Cell Protection Market
9.2.5.2.1 France Pancreatic Beta-Cell Protection Market by Product
9.2.5.2.2 France Pancreatic Beta-Cell Protection Market by Applications
9.2.5.3 Italy Pancreatic Beta-Cell Protection Market
9.2.5.3.1 Italy Pancreatic Beta-Cell Protection Market by Product
9.2.5.3.2 Italy Pancreatic Beta-Cell Protection Market by Applications
9.2.5.4 Spain Pancreatic Beta-Cell Protection Market
9.2.5.4.1 Spain Pancreatic Beta-Cell Protection Market by Product
9.2.5.4.2 Spain Pancreatic Beta-Cell Protection Market by Applications
9.2.5.5 United Kingdom Pancreatic Beta-Cell Protection Market
9.2.5.5.1 United Kingdom Pancreatic Beta-Cell Protection Market by Product
9.2.5.5.2 United Kingdom Pancreatic Beta-Cell Protection Market by Applications
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Pancreatic Beta-Cell Protection Market Overview
9.3.2 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.3.3 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.3.5 Asia-Pacific Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Pancreatic Beta-Cell Protection Market
9.3.5.1.1 Australia Pancreatic Beta-Cell Protection Market by Product
9.3.5.1.2 Australia Pancreatic Beta-Cell Protection Market by Applications
9.3.5.2 China Pancreatic Beta-Cell Protection Market
9.3.5.2.1 China Pancreatic Beta-Cell Protection Market by Product
9.3.5.2.2 China Pancreatic Beta-Cell Protection Market by Applications
9.3.5.3 India Pancreatic Beta-Cell Protection Market
9.3.5.3.1 India Pancreatic Beta-Cell Protection Market by Product
9.3.5.3.2 India Pancreatic Beta-Cell Protection Market by Applications
9.3.5.4 Japan Pancreatic Beta-Cell Protection Market
9.3.5.4.1 Japan Pancreatic Beta-Cell Protection Market by Product
9.3.5.4.2 Japan Pancreatic Beta-Cell Protection Market by Applications
9.3.5.5 South Korea Pancreatic Beta-Cell Protection Market
9.3.5.5.1 South Korea Pancreatic Beta-Cell Protection Market by Product
9.3.5.5.2 South Korea Pancreatic Beta-Cell Protection Market by Applications
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Pancreatic Beta-Cell Protection Market Overview
9.4.2 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.4.3 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.4.5 Middle East and Africa Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Pancreatic Beta-Cell Protection Market
9.4.5.1.1 South Africa Pancreatic Beta-Cell Protection Market by Product
9.4.5.1.2 South Africa Pancreatic Beta-Cell Protection Market by Applications
9.4.5.2 Saudi Arabia Pancreatic Beta-Cell Protection Market
9.4.5.2.1 Saudi Arabia Pancreatic Beta-Cell Protection Market by Product
9.4.5.2.2 Saudi Arabia Pancreatic Beta-Cell Protection Market by Applications
9.4.5.3 U.A.E Pancreatic Beta-Cell Protection Market
9.4.5.3.1 U.A.E Pancreatic Beta-Cell Protection Market by Product
9.4.5.3.2 U.A.E Pancreatic Beta-Cell Protection Market by Applications
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Pancreatic Beta-Cell Protection Market Overview
9.5.2 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis
9.5.3 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Product
9.5.4 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Applications
9.5.5 South and Central America Pancreatic Beta-Cell Protection Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Pancreatic Beta-Cell Protection Market
9.5.5.1.1 Brazil Pancreatic Beta-Cell Protection Market by Product
9.5.5.1.2 Brazil Pancreatic Beta-Cell Protection Market by Applications
9.5.5.2 Argentina Pancreatic Beta-Cell Protection Market
9.5.5.2.1 Argentina Pancreatic Beta-Cell Protection Market by Product
9.5.5.2.2 Argentina Pancreatic Beta-Cell Protection Market by Applications
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL PANCREATIC BETA-CELL PROTECTION MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. PANCREATIC BETA-CELL PROTECTION MARKET, KEY COMPANY PROFILES
12.1. BETA-CELL NV
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BETA-O2 TECHNOLOGIES LTD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOLINERX
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BOEHRINGER INGELHEIM
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. GALAXOSMITHKLINE
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GENENTECH
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. JANSSEN RESEARCH AND DEVELOPMENT
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. NOVARTIS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NOVO NORDISK
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PFIZER INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. SANOFI
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
12.12. TRANSITION THERAPEUTICS
12.12.1. Key Facts
12.12.2. Business Description
12.12.3. Products and Services
12.12.4. Financial Overview
12.12.5. SWOT Analysis
12.12.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Beta-Cell NV
2. Beta-O2 Technologies Ltd
3. BioLineRx
4. Boehringer Ingelheim
5. GalaxoSmithKline
6. Genentech
7. Janssen Research and Development
8. Novartis
9. Novo Nordisk
10. Pfizer Inc
11. Sanofi
12. Transition Therapeutics
TIPRE00011636
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.


Speak To Analyst
Pricing
  • $3000
  • $4550
  • $6550
  • $8550
    GET FREE SAMPLE PDF

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount